No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bone Density Conservation Agents / administration & dosage*
-
Bone Density Conservation Agents / adverse effects
-
Bone Diseases / etiology
-
Bone Diseases / mortality
-
Bone Diseases / prevention & control*
-
Clinical Trials, Phase III as Topic
-
Diphosphonates / administration & dosage*
-
Diphosphonates / adverse effects
-
Humans
-
Infusions, Intravenous
-
Multicenter Studies as Topic
-
Multiple Myeloma / complications
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / mortality
-
Multiple Myeloma / therapy*
-
Pamidronate
-
Quality of Life
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Risk Factors
-
Stem Cell Transplantation*
-
Time Factors
-
Transplantation, Autologous
-
Treatment Outcome
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Pamidronate